Ifg Advisory, LLC Co Diagnostics, Inc. Transaction History

Ifg Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$7.48 - $11.38 $116,882 - $177,823	-15,626 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$7.16 - $9.56 $535,317 - $714,753	-74,765 Reduced 82.71%	15,626 $128,000
Q1 2021 Apr 19, 2021	BUY	$8.52 - $19.21 $15,020 - $33,867	1,763 Added 1.99%	90,391 $862,000
Q4 2020 Feb 08, 2021	SELL	$9.3 - $15.19 $507,956 - $829,662	-54,619 Reduced 38.13%	88,628 $824,000
Q3 2020 Nov 02, 2020	BUY	$8.24 - $30.8 $677,023 - $2.53 Million	82,163 Added 134.51%	143,247 $1.95 Million
Q1 2020 May 11, 2020	BUY	$0.91 - $17.81 $55,586 - $1.09 Million	61,084 New	61,084 $465,000

5.59M

67.5K

174K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $12.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.